Cenobamate
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 317 publications
Bridging evidence gaps in dravet syndrome: real-world safety insights from under-reported antiseizure therapies.
Journal: Expert opinion on drug safety
Published: April 25, 2026
Precision management of cenobamate in drug-resistant epilepsy: integrating pharmacogenetics, therapeutic drug monitoring, and real-world clinical strategies.
Journal: Frontiers in pharmacology
Published: March 13, 2026
Early sedation-related adverse events with the cenobamate-clobazam combination in drug-resistant epilepsy: real-world preliminary observations.
Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Published: March 13, 2026
Hypersensitivity reaction risk when restarting cenobamate after discontinuation: Insights from a prolonged hospitalized cohort.
Journal: Epilepsia open
Published: February 22, 2026
Self-reported quality of life outcomes after Cenobamate initiation.
Journal: Epilepsy & behavior : E&B
Published: February 13, 2026
Cenobamate in pediatric drug-resistant epilepsy: real-world evidence from a two-center retrospective study.
Journal: European journal of pediatrics
Published: February 11, 2026
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.
Comparative Effectiveness of Brivaracetam, Cenobamate, Lacosamide, and Perampanel in Focal Epilepsy.
Journal: JAMA neurology
Published: February 09, 2026
Effectiveness of adjunctive low-dose clobazam in adults with focal drug-resistant epilepsy and incomplete response to cenobamate: A real-world study.
Journal: Epilepsia open
Published: January 28, 2026
Last Updated: 06/30/2026